Playground Global

Agility Robotics develops humanoid robots, specifically Digit, designed for automation in logistics and manufacturing environments. Their robots are aimed at addressing labor shortages by automating repetitive tasks.

Amber Bio is a biotechnology firm innovating gene editing to treat previously untreatable conditions.

Ayar Labs specializes in optical interconnect technology for AI infrastructure, developing co-packaged optics to accelerate data transfer.

Boxbot is revolutionizing warehouse operations through next-generation supply chain automation, utilizing AI-powered dynamic storage and logistics solutions.

d-Matrix powers next generation compute for generative AI inference, focusing on ultra-low latency batched inference and innovative AI computing solutions.

Element Zero is developing zero-emission technology to produce green metals from iron ore and other ores. Their patented electrochemical process utilizes renewable energy to convert metal ores into high-purity metals without releasing carbon dioxide, aiming to significantly reduce industrial emissions.

GigaCrop is focused on doubling crop yields through innovative photosynthesis technology, utilizing enzyme engineering and machine learning to overcome traditional agricultural limitations.

Ideon Technologies uses the energy from supernova explosions in space to image deep beneath the Earth’s surface. The world pioneer in cosmic-ray muon tomography, Ideon has developed the REVEAL™ Subsurface Intelligence Platform™, comprising an advanced suite of proprietary data-generation hardware, software, AI-powered services, and multi-physics fusion that provide x-ray-like visibility deep underground and unlock the exponential power of integrated spatial data.

Infinimmune systematically surfaces and engineers rare antibodies proven effective in humans, advancing them into clinical trials. They utilize a proprietary platform to discover and develop human-derived antibody medicines.

Pioneering the discovery of membrane-permeable & orally available cyclic-peptides. Insamo's mission is to transform how we discover drugs for some of the most challenging diseases using scalable machine learning.

Technology VC backing immigrant and cross-border founders in software, life sciences, and deep tech, leveraging ex-Google/Palantir product leadership and scientific expertise, with deep technical underwriting, content-heavy guidance, and breakout exits.

Targets companies applying modern computation (AI, simulation) to agriculture, mining, manufacturing, health and defense, leveraging partners's hard-science and national-security expertise to navigate regulation and dual-use challenges.

Boston venture capital firm focused on seed and early-stage companies, differentiating itself by actively supporting founders professional and personal growth. Invests across Pre-Seed, Seed, and Series A stages.

Early-stage, first-money-in partner for technically ambitious founders transforming the physical world (energy, defense, infrastructure, space, advanced manufacturing), underwriting high technical and regulatory risk.

Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startups with exceptional defensibility and operational guidance from GP Rob Ness's 2% Rule.